-
Signature
-
/s/ Debra E. Levin, attorney-in-fact
-
Stock symbol
-
BLCO
-
Transactions as of
-
Jul 25, 2022
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
7/27/2022, 07:38 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
BLCO |
Common Shares, No Par Value |
Award |
$0 |
+35K |
+42% |
$0.00 |
118K |
Jul 25, 2022 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The Reporting Person's title as an officer of the Issuer is Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals.